<ѻý>First-Line Nivolumab Plus Chemo Approved for Bladder Cancerѻý> Combination reduced risk of death by 22% Mar 07, 2024
<ѻý>First-Line Immunotherapy Alone Sufficient for Older NSCLC Patients, Study Suggestsѻý> Retrospective analysis finds similar OS, PFS whether or not patients also received chemotherapy Mar 07, 2024
<ѻý>A Blenrep Comeback? Cancer Vaccine for Dogs; U.K. Snubs Enhertuѻý> News, features, and commentary about cancer-related issues Mar 07, 2024
<ѻý>Novel Regimens Yield High Response Rates for Older, Hodgkin Lymphoma Patientsѻý> Talk of potential cure for some patients with brentuximab plus dacarbazine or nivolumab Mar 06, 2024
<ѻý>FDA OKs First Interchangeable Biosimilars for Denosumabѻý> New products will carry all the same indications as Prolia and Xgeva, though launch date unclear Mar 06, 2024
<ѻý>King Charles' Cancer Diagnosis Highlights Long Wait Times Across the Pondѻý> Survival for common cancers in the U.K. consistently lags behind Mar 06, 2024
<ѻý>IVF Helps Patients Trying to Build Families. An Alabama Court Put That in Doubtѻý> "Every month that you're not pregnant feels like grief" Mar 05, 2024
<ѻý>All-Oral AML Regimen Shows Promise for Older, Unfit Patientsѻý> Response rate of 64% in newly diagnosed patients, 46% in those with refractory/relapsed disease Mar 05, 2024
<ѻý>More Evidence Linking H. Pylori Infection to Colorectal Cancerѻý> Increased CRC incidence and mortality, significantly reduced by infection treatment Mar 05, 2024
<ѻý>Novel Therapy Promising for Radiation-Induced Oral Mucositisѻý> No patient with head and neck cancer developed a severe case during 7 weeks of treatment Mar 04, 2024
<ѻý>Gene-Guided Immunotherapy Misses Mark in Recurrent/Metastatic Head and Neck Cancerѻý> Few responses with or without guidance in small first step for "personalized" treatment Mar 04, 2024
<ѻý>FDA OKs Amivantamab as First-Line Lung Cancer Treatmentѻý> Bispecific drug lands full approval for NSCLCs with EGFR exon 20 insertion mutations Mar 04, 2024
<ѻý>Toxic Gas That Sterilizes Medical Devices Prompts Safety Rule Updateѻý> The EPA is set to take action after public outcry Mar 03, 2024
<ѻý>Taking Control of the Cancer Journeyѻý> Kathy Giusti gives patients and healthcare workers advice for navigating cancer treatment Mar 02, 2024 podcast
<ѻý>Vismodegib-RT Regimen Achieves High Rate of Disease Control in Head and Neck BCCѻý> Local control in 91% of cases at 1 year in small prospective trial Mar 01, 2024
<ѻý>Two Pembrolizumab Trials in Head and Neck Cancer Yield Divergent Resultsѻý> One first-line regimen led to worse OS, while another offers an additional option Mar 01, 2024
<ѻý>New Drugs Yield Limited Benefit; Big Jump in Drug Prices; AI Boost for Mammo Resultsѻý> News, features, and commentary about cancer-related issues Mar 01, 2024
<ѻý>When a Neurologist Asks for an MRI, You Order an MRIѻý> "This was going to be a lifelong battle" Mar 01, 2024 podcast
<ѻý>Robotic Surgery for Pancreatic Tumors Proves Safe, Feasible in Experienced Handsѻý> Shorter stays, faster surgeries, and less blood loss versus open surgery in Chinese study Feb 29, 2024
<ѻý>Study Tests Office-Based Transperineal Approach to Prostate Biopsiesѻý> Antibiotic-free option resulted in zero infections in randomized trial Feb 29, 2024 video
<ѻý>Cancer Prevention Strategies Linked to Mortality Reduction in BRCA Carriersѻý> Cohort studies indicate oophorectomy, breast MRI surveillance save lives, researchers say Feb 29, 2024
<ѻý>PROs for Cutaneous Chronic GVHD After Transplant Tied to Disease Severity, Mortalityѻý> Baseline QOL, symptom burden could inform risk stratification, treatment decisions Feb 28, 2024
<ѻý>In TNBC, Pathologic Complete Response May Vary by Race/Ethnicityѻý> Compared with white women, Black women less likely and Hispanic women more likely to achieve pCR Feb 27, 2024
<ѻý>Oregon Pathologist Reportedly Missed Cancer Diagnosesѻý> One patient received the news that she had cancer a year after breast biopsy Feb 27, 2024
<ѻý>More Population-Based Evidence That Screening for CRC Reduces Risk of Cancer Deathѻý> Large Swedish study shows 14% reduction in long-term CRC mortality, 16% reduction in all deaths Feb 27, 2024
<ѻý>Investigational Immunotherapy Combo Shows Promise for Advanced Solid Tumorsѻý> Objective response rate of 37.7% in patients with various solid tumors in phase I study Feb 26, 2024
<ѻý>Amy Schumer's Diagnosis; FDA Yanks Cancer Drug; Nursing Student Murderedѻý> Health news and commentary from around the Web gathered by ѻý staff Feb 26, 2024
<ѻý>Can Artificial Intelligence Improve Prior Authorization?ѻý> Possibly, but "complete transparency" about its use would be needed, expert says Feb 23, 2024
<ѻý>Changing the Surgical Paradigm in Oligometastatic NSCLCѻý> Propensity-score matched analysis suggests survival benefit with surgery to the primary tumor Feb 23, 2024
<ѻý>Transforming Shots Into Pills; 'Tip of the Iceberg' for TILs? Food Additives Warningѻý> News, features, and commentary about cancer-related issues Feb 23, 2024
<ѻý>Faster Cures, More Genetic Treatments: A Q&A With NIH's Joni Rutterѻý> The NCATS Biomedical Data Translator is giving researchers ideas for new disease therapies Feb 23, 2024
<ѻý>Make the Diagnosis: A Blue-Black Facial Nodule -- What's Your Best Guess?ѻý> A 64-year-old postal worker visited his doctor about a lesion that he first noticed on his face 2 months prior. Can you diagnose the patient? Feb 23, 2024
<ѻý>Another COVID Toll: Over 134,000 Undiagnosed Cancers During Height of Pandemicѻý> Diagnosis rates remained low throughout 2020, with mortality increase projected Feb 22, 2024
<ѻý>Male Fertility Problems in the Family Linked to Cancer Riskѻý> Low sperm levels were tied to specific cancers in family members Feb 22, 2024
<ѻý>Cabozantinib Plus Atezolizumab Improves PFS in Metastatic CRPCѻý> A non-hormonal therapy control arm is appropriate in trials, says Neeraj Agarwal, MD Feb 22, 2024 video
<ѻý>Elotuzumab Misses Mark Again as Frontline Treatment for Multiple Myelomaѻý> No PFS benefit from adding the monoclonal antibody to standard therapy Feb 20, 2024
<ѻý>Annual Breast Cancer Screening Starting at Age 40 Best, Modeling Study Saysѻý> Estimates suggest mortality was reduced by 42% with annual screening for this age group Feb 20, 2024
<ѻý>For Kids With Sickle Cell Disease Prescribed Opioids, No Patterns of Misuse Emergedѻý> Number of vaso-occlusive crises tied to days' supply Feb 19, 2024
<ѻý>Radioligand Therapy Continues to Show Promise for Metastatic CRPCѻý> Median OS of 15.5 months, PFS of 7.9 months with Ac-225-PSMA in heavily treated patients Feb 16, 2024
<ѻý>FDA OKs First Cellular Therapy for Melanomaѻý> Lifileucel approved as treatment for advanced melanoma after anti-PD-1 and targeted therapy Feb 16, 2024